Heritability and Metabolic Traits – Research during 2020 in a glance
Number, Impact factor, and citations of DDI’s published articles have increased significantly during 2020 as compared to previous years. Here we highlight some of the published work in the dep
DDI released a new tool PHARMAKU
Tailoring treatments for each patient with precision medicine. Modern medications save millions a year; however, most available drugs are “one size fits all” and fail to work similarly for everyon
AlQabas-The latest GeoHealth studies to tackle the diabetes epidemic
Dangers of COVID-19 increase with high blood sugar levels
Why are COVID-19 symptoms severe in young adults ?
Alanbaa-10% of COVID-19 patients w/o chronic diseases have antibodies that attack the immune system
AlQabas-Prof Fahd Almulla explains why COVID-19 effects young adults
AlJarida-DDI participates in a study to determine the cause of COVID-19 severity in young adults
Meet the Scientist – Dr. Anwar Mohammad
DR. ANWAR MOHAMMAD Meet the scientists behind DDI’s research Dr. Anwar joined DDI in 2012 as a scientist in the Department of Public Health. Since 2018, he has been working within the Bioch
COVID19: N720D AN ACE2 VARIANT WITH HIGHER AFFINITY TO TMPRSS2
The rate of infection and mortality of SARS-CoV-2 varies based on the geographical spread of the virus as a consequence of several factors such as isolation, quarantine, differences in the genetic ma
DDI joins COVIDIAB, an international group of researchers that aim to investigate newly diagnosed COVID-19-related diabetes.
Recent evidence emerges showing that COVID-19 may cause diabetes in patients with no previous history of diabetes. It has been well-established in the early months of the COVID-19 pandemic that ob
AlQabas-High blood sugar levels increase risk of COVID-19
Severity of COVID-19 increases with high blood glucose levels
It is in our genes!
New research study highlights differences in genetic risk for metabolic disease. In a recently published article in the Human Genetics Journal, Professor Fahd Al Mulla, Chief Scientific O
Dasman Diabetes Institute Honors the Kuwait Fire Service Directorate
The senior management of Dasman Diabetes Institute represented by Dr. Hilal Al-Sayer, Chairman of the Board of Trustees, Dr. Qais Al-Duwairi, Director-General, Dr. Faisal Al-Refaei, Chief Operati
DR. SARDAR SINDHU
Dr. Sardar joined DDI in 2014 and has been serving as Scientist II and Manager of the Animal and Imaging Core Facility since 2016. He received his Ph.D. in Immunology and Virology from the Univer
Markers for Inflammation in Obesity and Diabetes
DDI finds potentially critical biomarker of metabolic inflammation in obesity and diabetes Obesity, an important risk factor in the development of diabetes, is often associated with chronic infl
DDI Researchers Volunteer at Local Hospitals to Help with SARS-COV-2 Testing
Researchers at DDI have volunteered their time and expertise to help screen patients for COVID-19 A group of DDI researchers offered to volunteer their skills at different local hospitals to hel
COVID-19: DDI Find Possible Link Between Genetics and Disease Severity
Naturally occurring genetic variations in human populations may be the key to the differences in susceptibility to COVID-19 and the severity of its symptoms around the world. ACE2 and FURIN are im
Non-HDL cholesterol high in Asia
Imperial College London released the below News on Wednesday, June 3rd 2020. The below press release summarizes a recently published study that highlights DDI’s contributions from Dr Monira Alarouj a
© 2024 Dasman Diabetes Institute. All rights reserved.